Evolution of metallo-beta-lactamases in focus of the antibiotic resistance problem
Abstract
The article considers the place of metallo-beta-lactamases among the mechanisms of antibiotic resistance. These enzymes have important differences from serine beta-lactamases, which affect the mechanism of their catalytic activity, inhibition, rate of spread and evolution. The history of the study and the social significance of antibiotic resistance in general and beta-lactamases in particular are described. The classifications of enzymes that hydrolyze the beta-lactam ring are presented, the structure of the reaction center of metallo-beta-lactamases and a hypothetical model of its functioning are described. Two fundamentally different mechanisms of inhibition of metallo-beta-lactamases (zinc-dependent and zinc-independent) and their consequences for the development of therapeutic strategies are also considered. Metallo-beta-lactamases were distributed among non-pathogenic natural populations of bacteria, and then began to spread to pathogenic ones (initially gram-negative), which determines the importance of their study from the point of view of public health. The high rate of spread of these enzymes is due to their localization in structures such as integrons, insertion sequences and conjugation plasmids and can be illustrated by the example of the NDM enzyme, first isolated in New Delhi in 2009, which spread throughout the world in ten years and formed three dozen mutant variants. The fact that metallo-beta-lactamases arose in evolution twice is almost proven. Today, the phylogenetic relationships between different representatives of this enzyme family have been more precisely clarified and the presence of ten monophyletic groups has been established. The data presented in the article can serve as a starting point for planning comprehensive work on predicting the evolution of metallo-beta-lactamases, which carry serious risks for the treatment of infectious diseases.
Downloads
References
Ambler, R.P. (1980). The structure of β-lactamases. Philosophical Transactions of the Royal Society of London. B, Biological Sciences, 289(1036), 321-331. https://doi.org/10.1098/rstb.1980.0049
Banin, E., Hughes, D., Kuipers, O.P. (2017). Bacterial pathogens, antibiotics and antibiotic resistance. FEMS microbiology reviews, 41(3), 450-452. https://doi.org/10.1093/femsre/fux016
Bebrone, C. (2007). Metallo-β-lactamases (classification, activity, genetic organization, structure, zinc coordination) and their superfamily. Biochemical pharmacology, 74(12), 1686-1701. https://doi.org/10.1016/j.bcp.2007.05.021
Berglund, F., Johnning, A., Larsson, D.J., Kristiansson, E. (2021). An updated phylogeny of the metallo-β-lactamases. Journal of Antimicrobial Chemotherapy, 76(1), 117-123. https://doi.org/10.1093/jac/dkaa392
Blair, J.M., Webber, M.A., Baylay, A.J., Ogbolu, D.O., Piddock, L.J. (2015). Molecular mechanisms of antibiotic resistance. Nature reviews microbiology, 13(1), 42-51. https://doi.org/10.1038/nrmicro3380
Boyd, S.E., Livermore, D.M., Hooper, D.C., Hope, W.W. (2020). Metallo-β-lactamases: structure, function, epidemiology, treatment options, and the development pipeline. Antimicrobial agents and chemotherapy, 64(10), 10-1128. https://doi.org/10.1128/aac.00397-20
Charpentier, E., Courvalin, P. (1999). Antibiotic resistance in Listeria spp. Antimicrobial agents and chemotherapy, 43(9), 2103-2108. https://doi.org/10.1128/aac.43.9.2103
Church, N.A., McKillip, J.L. (2021). Antibiotic resistance crisis: challenges and imperatives. Biologia, 76(5), 1535-1550. https://doi.org/10.1007/s11756-021-00697-x
Diene, S.M., Pontarotti, P., Azza, S., Armstrong, N., Pinault, L., Chabrière, E., Raoult, D. (2023). Origin, diversity, and multiple roles of enzymes with metallo-β-lactamase fold from different organisms. Cells, 12(13), 1752. https://doi.org/10.3390/cells12131752
Frieri, M., Kumar, K., Boutin, A. (2017). Antibiotic resistance. Journal of infection and public health, 10(4), 369-378. https://doi.org/10.1016/j.jiph.2016.08.007
Garau, G., Di Guilmi, A.M., Hall, B.G. (2005). Structure-based phylogeny of the metallo-β-lactamases. Antimicrobial agents and chemotherapy, 49(7), 2778-2784. https://doi.org/10.1128/aac.49.7.2778-2784.2005
Hall, B.G., Barlow, M. (2005). Revised Ambler classification of β-lactamases. Journal of Antimicrobial Chemotherapy, 55(6), 1050-1051. https://doi.org/10.1093/jac/dki130
Ju, L.C., Cheng, Z., Fast, W., Bonomo, R.A., Crowder, M.W. (2018). The continuing challenge of metallo-β-lactamase inhibition: mechanism matters. Trends in pharmacological sciences, 39(7), 635-647.
Levy, S.B., Clowes, R.C., Koenig, E.L. (1981). Statement regarding worldwide antibiotic misuse. Molecular Biology, Pathogenicity, and Ecology of Bacterial Plasmids; Plenum: New York, NY, USA, 679-681.
Lin, J., Nishino, K., Roberts, M.C., Tolmasky, M., Aminov, R.I., Zhang, L. (2015). Mechanisms of antibiotic resistance. Frontiers in microbiology, 6, 34. https://doi.org/10.3389/fmicb.2015.00034
López, C., Delmonti, J., Bonomo, R.A., Vila, A.J. (2022). Deciphering the evolution of metallo-β-lactamases: a journey from the test tube to the bacterial periplasm. Journal of Biological Chemistry, 298(3), 101665. https://doi.org/10.1016/j.jbc.2022.101665
MacGowan, A., Macnaughton, E. (2017). Antibiotic resistance. Medicine, 45(10), 622–628. https://doi.org/10.1016/j.mpmed.2017.07.006
Mojica, M.F., Rossi, M.A., Vila, A.J., Bonomo, R.A. (2022). The urgent need for metallo-β-lactamase inhibitors: an unattended global threat. The Lancet Infectious Diseases, 22(1), e28-e34.
Munita, J.M., Arias, C.A. (2016). Mechanisms of antibiotic resistance. Virulence mechanisms of bacterial pathogens, 481-511. https://doi.org/10.1128/9781555819286.ch17
Olsen, J.E., Christensen, H., Aarestrup, F.M. (2006). Diversity and evolution of blaZ from Staphylococcus aureus and coagulase-negative staphylococci. Journal of Antimicrobial Chemotherapy, 57(3), 450-460. https://doi.org/10.1093/jac/dki492
O'Neill, J. (2014). Antimicrobial resistance: tackling a crisis for the health and wealth of nations. Rev. Antimicrob. Resist. 20 p.
Osmundsen, J.A. (1966). Are germs winning the war against people. Look, 18, 140-1.
Page, M.I., Badarau, A. (2008). The mechanisms of catalysis by metallo β‐lactamases. Bioinorganic chemistry and applications, 2008(1), 576297. https://doi.org/10.1155/2008/576297
Palzkill, T. (2013). Metallo‐β‐lactamase structure and function. Annals of the New York Academy of Sciences, 1277(1), 91-104. https://doi.org/10.1111/j.1749-6632.2012.06796.x
Podolsky, S.H. (2018). The evolving response to antibiotic resistance (1945–2018). Palgrave Communications, 4(1). https://doi.org/10.1057/s41599-018-0181-x
Rotondo, C.M., Wright, G.D. (2017). Inhibitors of metallo-β-lactamases. Current opinion in microbiology, 39, 96-105. https://doi.org/10.1016/j.mib.2017.10.026
Sabtu, N., Enoch, D.A., Brown, N.M. (2015). Antibiotic resistance: what, why, where, when and how? British medical bulletin, 116(1). https://doi.org/10.1093/bmb/ldv041
Tr, W. (2005). Metallo-β-lactamases: the quiet before the storm? Clin Microbiol Rev, 18, 306-325.
Urban-Chmiel, R., Marek, A., Stępień-Pyśniak, D., Wieczorek, K., Dec, M., Nowaczek, A., Osek, J. (2022). Antibiotic resistance in bacteria — A review. Antibiotics, 11(8), 1079. https://doi.org/10.3390/antibiotics11081079
Walsh, T.R., Toleman, M.A., Poirel, L., Nordmann, P. (2005). Metallo-β-lactamases: the quiet before the storm? Clinical microbiology reviews, 18(2), 306-325. https://doi.org/10.1128/cmr.18.2.306-325.2005
Wie, W.J., Yang, H.F., Ye, Y., Li, J.B. (2015). New Delhi metallo-β-lactamase-mediated carbapenem resistance: origin, diagnosis, treatment and public health concern. Chinese medical journal, 128(14), 1969-1976. https://doi.org/10.4103/0366‑6999.160566
Authors retain copyright of their work and grant the journal the right of its first publication under the terms of the Creative Commons Attribution License 4.0 International (CC BY 4.0), that allows others to share the work with an acknowledgement of the work's authorship.
